Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Contact form








 


Note! If you want an answer on a question you must specify your email address




Jan Lycke

Professor, adjungerad

Jan Lycke
Professor, adjungerad
jan.lycke@gu.se
+46 31-342 9047
0733-109149

Postal Address: Gröna stråket 11, plan 3, 41345 Göteborg
Visiting Address: Neurosjukvården, Gröna stråket 11, plan 3, SU/Sahlgrenska sjukhuset , 41345 Göteborg


Department of Clinical Neuroscience at Institute of Neuroscience and Physiology (More Information)
Box 430
405 30 Göteborg
Visiting Address: Blå stråket 7, plan 3, Sahlgrenska , 413 45 Göteborg

Latest publications

Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies
B. Van Wijmeersch, B. A. Singer, A. Boster, S. Broadley, O. Fernandez et al.
Multiple Sclerosis Journal, Journal article 2019
Journal article

Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis
M. Boremalm, A. Juto, Markus Axelsson, Lenka Novakova, T. Frisell et al.
European Journal of Neurology, Journal article 2019
Journal article

Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapies
Markus Axelsson, N. Dubuisson, Lenka Novakova, Clas Malmeström, G. Giovannoni et al.
Acta Neurologica Scandinavica, Journal article 2019
Journal article

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
Fredrik Piehl, Ingrid Kockum, Mohsen Khademi, Kaj Blennow, Jan Lycke et al.
Multiple Sclerosis Journal, Journal article 2018
Journal article

Showing 31 - 40 of 69

2015

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
J. Kuhle, G. Disanto, R. Dobson, R. Adiutori, L. Bianchi et al.
Multiple Sclerosis Journal, Journal article 2015
Journal article

2014

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: The Swedish experience
Joachim Burman, Ellen Iacobaeus, Anders Svenningsson, Jan Lycke, Martin Gunnarsson et al.
Journal of Neurology, Neurosurgery and Psychiatry, Journal article 2014
Journal article

Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis.
Markus Axelsson, Clas Malmeström, Martin Gunnarsson, Henrik Zetterberg, Peter Sundström et al.
Multiple sclerosis (Houndmills, Basingstoke, England), Journal article 2014
Journal article

2013

MS risk genes are transcriptionally regulated in CSF leukocytes at relapse
Margareta Jernås, Clas Malmeström, Markus Axelsson, Caroline Olsson, Intawat Nookaew et al.
Multiple sclerosis (Houndmills, Basingstoke, England), Journal article 2013
Journal article

The impact of rituximab therapy in multiple sclerosis on cerebrospinal fluid cell gene expression
Margareta Jernås, Clas Malmeström, Intawat Nookaew, Hans Wadenvik, Bob Olsson et al.
Multiple Sclerosis Journal: 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Conference contribution 2013
Conference contribution

Showing 31 - 40 of 69

Page Manager: Katinka Almrén|Last update: 9/1/2015
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
http://neurophys.gu.se/english/departments/clinical_neuroscience_and_rehabilitation/about-us/staff/?publicationPageNumber=4&selectedTab=2&feedbackForm=true&returnAddress=http%3A%2F%2Fneurophys.gu.se%2Fenglish%2Fdepartments%2Fclinical_neuroscience_and_rehabilitation%2Fabout-us%2Fstaff%2F%3Fprint%3Dtrue%26languageId%3D100001%26userId%3Dxlycja&recipientName=Katinka+Almr%E9n&encodedEmail=a2F0aW5rYS5hbG1yZW5AbmV1cm8uZ3Uuc2U&languageId=100001&userId=xlycja
Utskriftsdatum: 2019-12-07